ICLO.LTD – Trademark Portfolio
Entity Type: 03
ICLO.LTD has 5 U.S. trademark filings recorded with the United States Patent and Trademark Office (USPTO). Of these, 3 are successfully registered — a 60% registration rate. The portfolio includes marks such as HOMEDEN. Filings span 5 Nice Classification classes, with the highest activity in Class 44 (Medical Services) and Class 35 (Advertising & Business). This trademark owner is based in Jeju-si, Jeju-do.
#307, 21 Jungang-ro 14-gil
Jeju-si, Jeju-do 63169 , KR
Showing of trademarks Trademarks
Trademark Classifications
ICLO.LTD's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does ICLO.LTD have?
ICLO.LTD has 5 U.S. trademarks filed with the USPTO. Of these, 3 registered, 2 abandoned.
What trademark classes does ICLO.LTD file in?
ICLO.LTD files trademarks across 5 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 21 (Housewares). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are ICLO.LTD's most well-known trademarks?
ICLO.LTD's registered trademark portfolio includes well-known marks such as HOMEDEN. These are among 3 currently registered trademarks in the portfolio.
What is ICLO.LTD's trademark registration success rate?
ICLO.LTD has a 60% trademark registration rate, with 3 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.